A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds
Robin Carhart-Harris, Richard E. Daws, David Nutt
May 10, 2022 preprint DOI: 10.31234/osf.io/pdbf5 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Authors' response to critique |
|---|---|
| Topics | Psilocybin |
| Keywords | Skepticism Psychoanalysis Epistemology |
| Key points | Argues that the critique of their earlier work misinterprets the evidence and that their original conclusions about psilocybin's effects on depressed minds remain valid. |
Abstract
This document details an authors' response to a critique of their work entitled: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds.
Citations in the library
Cites 16
- A default mode of brain function Proceedings of the National Academy of Sciences January 16, 2001
- Experience sampling during fMRI reveals default network and executive system contributions to mind wandering. Proceedings of the National Academy of Sciences May 26, 2009
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences April 11, 2016
and 11 more in the library